Rare diseases
Investigational molecules
Locations
Study on the Safety and Tolerability of BMS-986435 in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
ItalyStudy on Cefepime for Patients with Chronic Kidney Disease on Peritoneal Dialysis Without Peritonitis
AustriaStudy on Zanubrutinib for Patients with Primary Cold Agglutinin Disease
BelgiumStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
AustriaStudy of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
BelgiumStudy on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis
AustriaStudy of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment
CzechiaStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
FranceStudy on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer
BelgiumStudy of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers
PolandStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
AustriaStudy on Radiotherapy and Durvalumab for Patients with Resectable Stage III Non-Small Cell Lung Cancer (NSCLC)
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
